Clinical Trials Directory

Trials / Completed

CompletedNCT02959814

Diagnostic Accuracy of On-line Quantitative Flow Ratio (QFR). FAVOR II Europe-Japan

Diagnostic Accuracy of On-line Quantitative Flow Ratio. Functional Assessment by Virtual Online Reconstruction (The FAVOR II Europe-Japan Study)

Status
Completed
Phase
Study type
Observational
Enrollment
329 (actual)
Sponsor
Aarhus University Hospital Skejby · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Quantitative Flow Ratio (QFR) is a novel method for evaluating the functional significance of coronary stenosis. QFR is assessed by calculation of the pressure in the vessel based on two angiographic projections. The purpose of the FAVOR II study is to evaluate the diagnostic accuracy of on-line QFR compared to 2D Quantitative Coronary Angiography (QCA) with FFR as gold standard.

Detailed description

Background: Patients at high risk of having one or more coronary stenosis are evaluated routinely by invasive coronary angiography (CAG). Lesions are often quantified by QCA, but fractional flow reserve is increasingly used to assess functional significance of identified stenosis. FFR is assessed during CAG by advancing a wire with a pressure transducer towards the stenosis and measure the ratio in pressure between the two sides of the stenosis during medical induced maximum blood flow (hyperaemia). The solid evidence for FFR evaluation of coronary stenosis and the relative simplicity in performing the measurements have supported adoption of an FFR based strategy in many centers but the need for interrogating the stenosis by a pressure wire, the cost of the wire, and the drug inducing hyperaemia limits more widespread adoption. Quantitative Flow Ratio is a novel method for evaluating the functional significance of coronary stenosis by calculation of the pressure drop in the vessel based on two angiographic projections. The FAVOR I study (Tu et al.), showed promising results for core laboratory QFR analysis in selected patients. The purpose of the FAVOR II study is to evaluate the feasibility and diagnostic precision of in-procedure QFR during CAG in comparison to QCA with FFR as gold standard for physiological lesion evaluation. Hypothesis: QFR has superior sensitivity and specificity for detection of functional significant lesions in comparison to QCA with FFR as gold standard Methods: Prospective, observational, multicenter study with inclusion of 310 patients. Patients with indication for FFR are enrolled. At least two angiographic projections are acquired during resting conditions. QFR is calculated in-procedure using the Medis Suite application and simultaneously to the operator performing the FFR measurement. The QFR observer is blinded to the FFR measurement. QFR is reassessed off-line by the Interventional Coronary Imaging Core Laboratory, Aarhus University, Denmark, blinded to FFR and in-procedure QFR results. FFR is assessed by core laboratory reading, blinded to QFR results. All data are entered and stored in a protected and logged trial management system (TrialPartner, Aarhus University, Denmark).

Conditions

Interventions

TypeNameDescription
OTHERQFR (observational)QFR assessment by Medis Suite, Medis medical imaging B.V., The Netherlands

Timeline

Start date
2017-02-22
Primary completion
2017-10-17
Completion
2018-06-01
First posted
2016-11-09
Last updated
2020-01-13
Results posted
2020-01-13

Locations

10 sites across 7 countries: Denmark, France, Germany, Italy, Japan, Netherlands, United Kingdom

Source: ClinicalTrials.gov record NCT02959814. Inclusion in this directory is not an endorsement.